NVIDIA $NVDA JUST LAUNCHED BIONEMO AGENT TOOLKIT AND IT COULD CHANGE HOW DRUG DISCOVERY WORKS
More than 50 companies are already using it including Anthropic, OpenAI, Eli Lilly $LLY, Databricks, Snowflake $SNOW, Dassault Systèmes, and Schrödinger.
Jensen Huang on what this actually does:
"Frontier models are the brains. BioNeMo is the scientific toolbox. Together, they give AI agents the skills of a PhD research assistant and the speed of a supercomputer."
What the toolkit enables AI agents to do right now:
Virtual drug screening: compress screening timelines from days to minutes by generating and docking compounds automatically.
Genomic analysis: transform raw sequencing data into prioritized genetic targets.
Protein design: design and validate candidates computationally before lab work begins.
Medical imaging: process and reason over imaging data to accelerate biomarker discovery.
The University of Washington's Institute for Protein Design is already using it to run RosettaFold3 at 2x faster performance than the prior generation.